These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7242736)

  • 1. [Category T1NXM0 bladder cancer treated with radium implantation or transurethral resection].
    van der Werf-Messing B; Hop WC
    Ned Tijdschr Geneeskd; 1981 May; 125(21):825-9. PubMed ID: 7242736
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinoma of the urinary bladder (category T1NxM0) treated either by radium implant or by transurethral resection only.
    van der Werf-Messing B; Hop WC
    Int J Radiat Oncol Biol Phys; 1981 Mar; 7(3):299-303. PubMed ID: 7024220
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinoma of the urinary bladder category T3 NX MO treated by preoperative irradiation followed by simple cystectomy.
    van der Werf-Messing BH; Friedell GH; Menon RS; Hop WC; Wassif SB
    Prog Clin Biol Res; 1988; 260():453-60. PubMed ID: 3129735
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoma of the urinary bladder category T2, T3, NX, MO treated by interstitial radium implant.
    van der Werf-Messing BH; Menon RS; Hop WC
    Prog Clin Biol Res; 1988; 260():511-24. PubMed ID: 3129736
    [No Abstract]   [Full Text] [Related]  

  • 5. [The place of radiumpuncture in the management of malignant tumors of the bladder. Apropos of 64 cases].
    Gayet R; Favre JP; Sgro JC
    Ann Urol (Paris); 1971 Dec; 5(4):235-9. PubMed ID: 5157693
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer of the urinary bladder category T2, T3, (NxMo) treated by interstitial radium implant: second report.
    van der Werf-Messing B; Menon RS; Hop WC
    Int J Radiat Oncol Biol Phys; 1983 Apr; 9(4):481-5. PubMed ID: 6853251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?
    Pos F; Horenblas S; Dom P; Moonen L; Bartelink H
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):678-86. PubMed ID: 15708245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transurethral microwave tissue coagulation therapy for carcinoma of urinary bladder: an analysis of 35 patients].
    Wu Z; Lu H; Luo S
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):148-50. PubMed ID: 11776861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brachytherapy for urinary bladder cancer].
    González González D; Haitze van der Veen J; Ypma AF; Blank LE; Hoestra CJ; Veen RE
    Arch Esp Urol; 1999; 52(6):655-61. PubMed ID: 10484849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracavitary radium therapy of bladder tumors.
    Sell A
    Dan Med Bull; 1967 Jan; 14(1):21-6. PubMed ID: 6016784
    [No Abstract]   [Full Text] [Related]  

  • 11. Dynamic dose-feedback prostate brachytherapy in patients with large prostates and/or planned transurethral surgery before implantation.
    Acher PL; Popert R; Morris SL; Potters L; Austin-Smith SL; Johnson UH; Nichol JE; Beaney RP
    BJU Int; 2007 May; 99(5):1066-71. PubMed ID: 17233801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of variant histology on the outcome of bladder cancer treated with curative intent.
    Black PC; Brown GA; Dinney CP
    Urol Oncol; 2009; 27(1):3-7. PubMed ID: 18367107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience.
    Nieuwenhuijzen JA; Pos F; Moonen LM; Hart AA; Horenblas S
    Eur Urol; 2005 Aug; 48(2):239-45. PubMed ID: 16005375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta-hCG producing urothelial carcinoma of the urinary bladder: a case report].
    Sugimoto K; Hashimoto K; Esa A; Park YC
    Hinyokika Kiyo; 2008 Apr; 54(4):289-92. PubMed ID: 18516923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.
    Denzinger S; Wieland WF; Otto W; Filbeck T; Knuechel R; Burger M
    BJU Int; 2008 Mar; 101(5):566-9. PubMed ID: 17986289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience.
    Serretta V; Lo Greco G; Pavone C; Pavone-Macaluso M
    J Urol; 1998 Apr; 159(4):1187-91. PubMed ID: 9507829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of intrauterine and intravaginal radium in the treatment of carcinoma of the bladder in women.
    Ariaratnam LS; Berger PS; Eisen HM; Smith HS; Botstein C
    Radiology; 1976 Jun; 119(3):669-72. PubMed ID: 935407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
    Kollmeier MA; Stock RG; Cesaretti J; Stone NN
    J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative management of low risk superficial bladder tumors.
    Pruthi RS; Baldwin N; Bhalani V; Wallen EM
    J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.